Dehaier Medical Wins Guizhou Province Medical Equipment Procurement Bid
January 08 2013 - 7:30AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that it has successfully
bid on a medical equipment procurement agreement valued at
approximately RMB 4 million, worthy of $650,000. The procurement
agreement is with Beijing Kanglian Medicine Company and is part of
the China Development Bank's ("CDB") Rural Medical and Healthcare
Infrastructure Project in Guizhou province.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier
Medical said, "Dehaier will provide Phillips Color Doppler
Ultrasound machines to county hospitals and clinics in Guizhou, a
province in southwest China with approximately 35 million
residents. Bulk procurement contracts like this one reflect well on
our decision to devote our team's time and resources to grow our
government-level projects. We are pleased to see our efforts in the
first half of the year result in an increasingly mature business
for the Company. Moving forward, we will dedicate even more energy
to developing these governmental infrastructure initiatives."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding internal management change.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, future developments
in payment for and demand for medical equipment and services,
implementation of and performance under the joint venture agreement
by all parties, and other risks contained in reports filed by the
company with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether
made by or on behalf of the company, are expressly qualified by the
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. In addition, the company
disclaims any obligation to update any forward-looking statements
to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024